Equities research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Pfizer in a report released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback